News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) Reaches Milestone in DuoBody Platform Collaboration With Janssen Biotech Inc.


8/26/2013 9:38:59 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; August 26, 2013 – Genmab A/S (OMX: GEN) announced today it has reached another milestone in its DuoBody technology platform collaboration with Janssen Biotech, Inc. and its affiliates (“Janssen”), triggering a $1 million payment. The milestone is for achieving technical proof-of-concept for the second DuoBody product candidate.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES